ACE Inhibitor-Induced Angioedema

Journal of Allergy and Clinical Immunology: In Practice

Volumn 1, Issue 5, 2013, Pages 442-445

  Baram, Michael ^a   Kommuri, Anand ^a   Sellers, Subhashini A ^a   Cohn, John R ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

ACE; Angioedema; Bradykinin; Ecallantide

Indexed keywords

ADRENALIN; AMLODIPINE; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ECALLANTIDE; FAMOTIDINE; LISINOPRIL; METHYLPREDNISOLONE; TAMSULOSIN; BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; ICATIBANT; PEPTIDE;

ADULT; AFRICAN AMERICAN; ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; EXTUBATION; FACE EDEMA; HEART INFARCTION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; LARYNGOSCOPY; LARYNX EDEMA; MALE; MEDICAL HISTORY; PATIENT COMPLIANCE; PROSTATE CANCER; RESPIRATORY TRACT INTUBATION; SEIZURE; THROAT DISEASE; ANALOGS AND DERIVATIVES; ANGIOEDEMA; CHEMICALLY INDUCED; MIDDLE AGED;

ANGIOEDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONISTS; DYSPNEA; HUMANS; LISINOPRIL; MALE; MIDDLE AGED; PEPTIDES;

EID: 84883395227     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2013.07.005     Document Type: Article

References (27)

1. Israili Z.H., Hall W.D. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med 1992, 117:234-242.
2. Mullins R.J., Shanahan T.M., Dobson R.T. Visceral angioedema related to treatment with an ACE inhibitor. Med J Aust 1996, 165:319-321.
3. Orr K.K., Myers J.R. Intermittent visceral edema induced by long-term enalapril administration. Ann Pharmacother 2004, 38:825-827.
4. Byrne T.J., Douglas D.D., Landis M.E., Heppell J.P. Isolated visceral angioedema: an underdiagnosed complication of ACE inhibitors?. Mayo Clin Proc 2000, 75:1201-1204.
5. Dicpinigaitis P.V. Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines. Chest 2006, 129(suppl):169S-173S.
6. Dean D.E., Schultz D.L., Powers R.H. Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease. JForensic Sci 2001, 46:1239-1243.
7. Vleeming W., van Amsterdam J.G., Stricker B.H., de Wildt D.J. ACE inhibitor-induced angioedema. Incidence, prevention and management. Drug Saf 1998, 18:171-188.
8. Gibbs C.R., Lip G.Y., Beevers D.G. Angioedema due to ACE inhibitors: increased risk in patients of African origin. Br J Clin Pharmacol 2001, 48:861-865.
9. Miller D.R., Oliveria S.A., Berlowitz D.R., Fincke B.G., Stang P., Lillienfeld D.E. Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors. Hypertension 2008, 51:1624-1630.
10. Consumer Reports Health Best Buy Drugs. Using ACE inhibitors to treat: high blood pressure and heart disease. Comparing effectiveness, safety, and price. ConsumerReportsHealth.org/BestBuyDrugs; 2011.
11. McDaniel C., Baram M., Wordell C., Cohn J.R. 933: Ecallantide treatment for angiotensin converting enzyme inhibitor induced angioedema (Acei-Ia): a case series and pharmacoeconomic assessment. Crit Care Med 2011, 39:260.
12. Byrd J.B., Adam A., Brown N.J. Angiotensin-converting enzyme inhibitor-associated angioedema. Immunol Allergy Clin North Am 2006, 26:725-737.
13. Bas M., Adams V., Suvorava T., Niehues T., Hoffmann T.K., Kojda G. Nonallergic angioedema: role of bradykinin. Allergy 2007, 62:842-856.
14. Nussberger J., Cugno M., Amstutz C., Cicardi M., Pellacani A., Agostoni A. Plasma bradykinin in angio-oedema. Lancet 1998, 351:1693-1697.
15. Vasekar M., Craig T.J. ACE inhibitor-induced angioedema. Curr Allergy Asthma Rep 2012, 12:72-78.
16. Adam A., Cugno M., Molinaro G., Perez M., Lepage Y., Agostoni A. Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors. Lancet 2002, 359:2088-2089.
17. Lefebvre J., Murphey L.J., Hartert T.V., Jiao Shan R., Simmons W.H., Brown N.J. Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedema. Hypertension 2002, 39:460-464.
18. Bernstein J.A., Qazi M. Ecallantide: its pharmacology, pharmacokinetics, clinical efficacy and tolerability. Expert Rev Clin Immunol 2010, 6:29-39.
19. Agostoni A., Aygören-Pürsün E., Binkley K.E., Blanch A., Bork K., Bouillet L., et al. Hereditary and acquired angioedema: problems and progress: Proceedings of the Third C1 Esterase Inhibitor Deficiency Workshop and beyond. JAllergy Clin Immunol 2004, 114(suppl):S51-131.
20. Bernstein J.A., Moellman J. Emerging concepts in the diagnosis and treatment of patients with undifferentiated angioedema. Int J Emerg Med 2012, 5:39.
21. Cicardi M., Banerji A., Bracho F., Malbrán A., Rosenkranz B., Riedl M., et al. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. NEngl J Med 2010, 363:532-541.
22. Lumry W.R., Li H.H., Levy R.J., Potter P.C., Farkas H., Moldovan D., et al. Randomized placebo-controlled trial of the bradykinin B(2) receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial. Ann Allergy Asthma Immunol 2011, 107:529-537.
23. Bas M., Greve J., Stelter K., Bier H., Stark T., Hoffmann T.K., et al. Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series. Ann Emerg Med 2010, 56:278-282.
24. Beavers C.J., Dunn S.P., Macaulay T.E. The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema. Ann Pharmacother 2011, 45:520-524.
25. Haymore B.R., Yoon J., Mikita C.P., Klote M.M., DeZee K.J. Risk of angioedema with angiotensin receptor blockers in patients with prior angioedema associated with angiotensin-converting enzyme inhibitors: a meta-analysis. Ann Allergy Asthma Immunol 2008, 101:495-499.
26. Malde B., Regalado J., Greenberger P.A. Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Ann Allergy Asthma Immunol 2007, 98:57-63.
27. Toh S., Reichman M.E., Houstoun M., Ross Southworth M., Ding X., Hernandez A.F., et al. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system. Arch Intern Med 2012, 172:1582-1589.